Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
When appetite suppression alone fails to drive further body recomposition, clinicians must evaluate new weight loss peptides that target distinct biological pathways
AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
The needle's siliconized three-facet bevel ensures smooth insertion, while color-coded hubs make it easy to identify the gauge
(Biochem Pharmacol 2018) documented a reduction of -35% in white adipose tissue, -40% in adipocyte volume, -5.1% in body weight and -30% in plasma cholesterol in just 11 days in obese mice (DIO), without any change in food intake
US$ 29.52
US$ 21.92
US$ 28.78
US$ 24.35
US$ 28.68
US$ 23.47
US$ 27.87
US$ 23.89
